Nanopharma Technologies, Inc. is a drug development company which develops technologies for the pharmaceutical industry and the anti-bacterial market in particular. Nanopharma acquires and develops novel compounds to be used as antibiotics and/or drug delivery tools. Current research and development efforts are focused on a new class of narrow-spectrum antibiotics highly specific against acute infectious diseases such as MRSA, Tuberculosis and Anthrax, as well as a drug delivery platform using nanoparticle technology
